Shepherd Street Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Shepherd Street Advisors's EW Position: Q2 2026 in Review
Shepherd Street Advisors increased its Edwards Lifesciences (EW) stake by 8.9% in Q2 2026, buying an estimated $38.1K and bringing the position to 5,589 shares worth $488K. The position accounts for 0.43% of the portfolio, ranked #59.
Shepherd Street Advisors first reported a position in EW in Q4 2025 and has held it in 3 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Shepherd Street Advisors held 5,589 shares of Edwards Lifesciences worth $488K as of Q2 2026.
- Shepherd Street Advisors bought 455 Edwards Lifesciences shares in Q2 2026, an estimated $38.1K.
- Edwards Lifesciences made up 0.43% of Shepherd Street Advisors's portfolio in Q2 2026, its #59 holding.
- Shepherd Street Advisors first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Shepherd Street Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.